Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

DSCC1 Identified as Promising Tumor Biomarker and Potential Therapeutic Target Through Comprehensive Multi-omics Analysis and Experimental Validation.

Molecular biotechnology - 1 Feb 2026

Cheng Wei, Lin Peng

Abstract excerpt

As a component of the alternative replication factor C (RFC) complex, DSCC1 plays a significant role in cancer progression due to its aberrant expression. However, the potential function of DSCC1 in a pan-cancer context remains unclear. In this study, we conducted a comprehensive analysis of DSCC1's role in tumors by integrating multi-omics bioinformatics tools. First, we utilized various databases to compare the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers, Tumor
Share to Cell Proliferation
Share to Computational Biology

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Epigenesis, Genetic

Share to Gene Expression Regulation, Neoplastic

Share to Multiomics

Share to Transcriptome

Share to Tumor Microenvironment

Source

Identifiers

PMID: 39992486
DOI: 10.1007/s12033-025-01404-w

Genes

DSCC1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

DSCC1 Identified as Promising Tumor Biomarker and Potential Therapeutic Target Through Comprehensive Multi-omics Analysis and Experimental Validation.PMID 39992486Read ↗

Decoding the DSCC1 gene as a pan-cancer biomarker in human cancers via comprehensive multi-omics analysesSemantic proximity Read ↗

Integrated Multi-Omics Characterization of<em> WASHC2C</em> Reveals Tumor-Specific Molecular, Clinical, and Immunological Associations Across Human CancersSemantic proximity Read ↗

Identifying the Role of NUDCD1 in Human Tumors from Clinical and Molecular MechanismsSemantic proximity Read ↗

Multi-omics analysis of the potential of MACC1 as a biomarker and therapeutic target for colonic adenocarcinomaSemantic proximity Read ↗

Oncogenic Potential of Replication Factor C Subunit 4: Correlations with Tumor Progression and Assessment of Potential InhibitorsSemantic proximity Read ↗

Pan-cancer analysis reveals the value of FDX1 as a novel biomarker in the prognosis and immunotherapy in human tumorsSemantic proximity Read ↗

Pan-cancer landscape of protein kinase D3: An integrative TCGA multi-omics analysis of clinical, molecular, and immunological roles.Semantic proximity Read ↗

Whole Exome and Transcriptome Sequencing of Stage-Matched, Outcome-Differentiated Cutaneous Squamous Cell Carcinoma Identifies Gene Expression Patterns Associated with Metastasis and Poor OutcomesSemantic proximity Read ↗

DHCR7 as a Prognostic and Immunological Biomarker in Human Pan-Cancer: A Comprehensive Evaluation.Semantic proximity Read ↗

Pan-cancer analyses confirmed the cuproptosis-related gene LIPT1 as an immunotherapy predictor and prognostic biomarkerSemantic proximity Read ↗

Systematic pan-cancer analysis identifies cuproptosis-related gene DLAT as an immunological and prognostic biomarkerSemantic proximity Read ↗

Comprehensive pan-cancer analysis of inflammatory age-clock-related genes as prognostic and immunity markers based on multi-omics dataSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.